Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma.

Authors :: Crouzet L
Edeline J
Le Du F
Boucher E
Audrain O
Raoul JL
Source :: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2012 May; Vol. 51 (5), pp. 687-8. Date of Electronic Publication: 2012 Feb 22.
Publication Year :: 2012

Subjects :: Deoxycytidine adverse effects
Disease Progression
Hemolytic-Uremic Syndrome therapy
Humans
Male
Middle Aged
Prognosis
Gemcitabine
Antimetabolites, Antineoplastic adverse effects
Bile Duct Neoplasms drug therapy
Bile Ducts, Intrahepatic drug effects
Cholangiocarcinoma drug therapy
Deoxycytidine analogs & derivatives
Hemolytic-Uremic Syndrome chemically induced
Jaundice chemically induced

Full Text Access

Tools